As is similar to our findings for patients with MCI or AD, circulating CLDN-5 levels are elevated in other CNS diseases, including ischemic stroke, bipolar disorder, and obsessive–compulsive disorder [22,23,24]. This evidence concerns the gene CLDN5 and Alzheimer disease.